CJC-1295 + Ipamorelin Research Peptides with Third-Party COA
When conducting preclinical investigations into growth hormone dynamics, verifying compound purity and identity is paramount for laboratory reproducibility. PX1 Research provides USA-manufactured CJC-1295 and Ipamorelin research compounds backed by comprehensive, lot-specific Certificates of Analysis (COAs) generated by independent ISO 17025 accredited laboratories.
Quick answer
When conducting preclinical investigations into growth hormone dynamics, verifying compound purity and identity is paramount for laboratory reproducibility. PX1 Research provides USA-manufactured CJC-1295 and Ipamorelin research compounds backed by comprehensive, lot-specific Certificates of Analysis (COAs) generated by independent ISO 17025 accredited laboratories.
Key takeaways
- A [CJC-1295](/research-peptides/cjc-1295-no-dac) and [Ipamorelin](/research-peptides/ipamorelin) research compound supplied with a [Certificate of Analysis](/research-peptides/what-is-a-coa-for-peptides) (COA) provides quantitative verification of identity, high purity (≥98% via RP-HPLC), mass verification (ESI-MS), and minimal endotoxin levels (<0.01 EU/mg).
- [CJC-1295](/research-peptides/cjc-1295-no-dac) (specifically Modified GRF 1-29) functions as a synthetic analog of Growth Hormone-Releasing Hormone (GHRH), binding selectively to the GHRH receptor on anterior pituitary somatotropes.
- A primary focus of growth hormone secretagogue literature is receptor selectivity.
- A valid [Certificate of Analysis](/research-peptides/what-is-a-coa-for-peptides) for research peptides must include both Quantitative Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Electrospray Ionization Mass Spectrometry (ESI-MS).
Direct Answer: CJC-1295 and Ipamorelin with COA Explained
A CJC-1295 and Ipamorelin research compound supplied with a Certificate of Analysis (COA) provides quantitative verification of identity, high purity (≥98% via RP-HPLC), mass verification (ESI-MS), and minimal endotoxin levels (<0.01 EU/mg). This documentation ensures baseline purity and batch consistency necessary for controlled, reproducible preclinical growth hormone secretagogue research.
Researchers evaluating dual-action growth hormone secretagogues require verified chemical parameters to isolate experimental variables. A authentic COA confirms that the peptide sequence is free from chemical cross-reactivity, heavy metals, or residual synthesis reagents that could distort receptor binding assays or cell culture viability.
Dual Secretagogue Dynamics: Synergistic GHRH and GHRP Mechanisms
CJC-1295 (specifically Modified GRF 1-29) functions as a synthetic analog of Growth Hormone-Releasing Hormone (GHRH), binding selectively to the GHRH receptor on anterior pituitary somatotropes. Concurrently, Ipamorelin operates as a selective Ghrelin/Growth Hormone Secretagogue Receptor (GHS-R1a) agonist. When combined in preclinical models, these compounds exhibit a complementary signal cascade that amplifies endogenous growth hormone secretion.
In cell culture models and animal assays, activating both pathway arms simultaneously yields a synergistic rather than merely additive GH release profile. Researchers utilizing CJC-1295 / Ipamorelin blends study how dual stimulation mimics natural physiological GH pulsatility. To review full biological profiles of these secretagogues, explore our comprehensive growth hormone secretagogues catalog.
Preclinical Literature: Pulsatile GH Release Without Adrenocortical Spikes
A primary focus of growth hormone secretagogue literature is receptor selectivity. Traditional GHRP peptides often trigger secondary cascades that elevate systemic stress hormones. In contrast, preclinical trials demonstrate that Ipamorelin selectively targets the GHS-R1a receptor without stimulating significant adrenocorticotropic hormone (ACTH), cortisol, or prolactin release.
In vitro somatotrope assays and rodent models demonstrate that CJC-1295 extends the half-life of GHRH signaling while maintaining natural pulse frequency. In vitro data indicate that combining CJC-1295 with Ipamorelin preserves baseline physiological rhythmicity, offering laboratory researchers an ideal model for assessing tissue repair, metabolic flux, and protein synthesis kinetics. Additional mechanical documentation can be accessed in the PX1 Research library hub.
Deconstructing a Quality COA: RP-HPLC and ESI-MS Analytics
A valid Certificate of Analysis for research peptides must include both Quantitative Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Electrospray Ionization Mass Spectrometry (ESI-MS). RP-HPLC determines overall chemical purity by separating the target peptide from synthesis truncated sequences, optical isomers, or protecting group adducts. A passing standard at PX1 Research requires an HPLC chromatogram area of ≥98% corresponding to the primary target peak.
Mass Spectrometry (ESI-MS) verifies the absolute molecular weight of the peptide chain. For CJC-1295 (Modified GRF 1-29, molecular weight ~3367.9 Da) and Ipamorelin (molecular weight ~711.9 Da), ESI-MS confirms that the synthesized sequence matches exact theoretical mass parameters down to fractional atomic mass units, ruling out incorrect amino acid substitution or partial sequence degradation.
Endotoxin Testing Standards for Cell Culture and Animal Studies
Bacterial endotoxins (lipopolysaccharides) represent a significant confounding variable in laboratory settings. In cell culture models, endotoxins activate Toll-like receptor 4 (TLR4), causing inflammatory cytokine expression that skews downstream gene expression and cell viability assays. In rodent models, elevated endotoxin levels induce acute febrile responses and alter neuroendocrine function.
PX1 Research subjects every batch of research peptides to Chromogenic Recombinant Factor C (rFC) or Limulus Amebocyte Lysate (LAL) testing to confirm endotoxin levels below 0.01 EU/mg. This rigorous standard guarantees that observations recorded during growth hormone secretagogue studies stem purely from peptide-receptor interaction rather than pyrogenic contamination. You can inspect all available batch-verified items across our complete research peptide selection.
Comparative Analysis: CJC-1295 + Ipamorelin vs. Related Secretagogues
Understanding where CJC-1295 and Ipamorelin fit within the secretagogue landscape requires comparative evaluation against single-target or broader-spectrum peptides. While first-generation secretagogues like GHRP-2 and GHRP-6 stimulate robust GH release, preclinical literature notes substantial off-target elevation of cortisol and appetite-stimulating ghrelin pathways.
Conversely, specialized single-target compounds such as Tesamorelin exhibit potent GHRH activity but lack the ghrelin-receptor co-activation provided by Ipamorelin. The combination of CJC-1295 (No DAC) and Ipamorelin offers a uniquely balanced research paradigm, providing synergistic GH amplification with clean receptor selectivity. To understand structural differences between GHRH analogs, read our deep-dive analysis comparing CJC-1295 vs Ipamorelin mechanisms.
Laboratory Reconstitution and Handling Procedures
Lyophilized CJC-1295 and Ipamorelin combinations must be handled using strict aseptic technique within a certified laminar flow hood to maintain sterility. The standard laboratory reconstituting agent is Bacteriostatic Water (0.9% benzyl alcohol) or Sterile Normal Saline (0.9% NaCl), depending on downstream assay compatibility.
When introducing solvent into the lyophilized peptide vial, direct the diluent stream against the glass wall rather than directly onto the cake to prevent shear stress degradation. Allow the cake to dissolve naturally via gentle swirl agitation; never vortex peptide solutions. Detailed protocols and bulk supply allocations for institutional laboratories are detailed on our wholesale accounts portal.
Storage Conditions for Lyophilized and Solubilized Aliquots
Lyophilized peptide complexes maintain long-term stability when stored at -20°C or -80°C in a desiccated, light-protected environment. Under these conditions, structural integrity and biological activity remain stable for extended periods without significant hydrolysis or peptide bond cleavage.
Once reconstituted, peptide solutions should be aliquoted into single-use polypropylene tubes to prevent freeze-thaw degradation cycles. Solubilized aliquots held at 2°C to 8°C should generally be utilized within 14 to 28 days. Avoid standard frost-free freezers for long-term storage, as temperature fluctuation cycles accelerate molecular breakdown.
Why Laboratory Quality Matters: The PX1 Research Difference
Research outcomes are only as reliable as the reagents used to generate them. PX1 Research manufactures all research compounds within state-of-the-art, GMP-compliant facilities located in the USA. Every production lot undergoes independent verification by third-party ISO 17025 accredited analytical laboratories.
We guarantee complete transparency by making full HPLC, MS, and endotoxin COA documentation accessible directly for every batch. Orders ship directly from our fulfillment centers in California and Arizona, with same-day shipping available Monday through Friday for orders placed before daily cutoff times, ensuring your laboratory maintains uninterrupted workflow integrity.
Frequently Asked Questions
What information should I look for on a CJC-1295 / Ipamorelin COA?
A valid COA should display an RP-HPLC chromatogram showing ≥98% purity, an ESI-MS mass spectrum confirming exact molecular weight, LAL/rFC endotoxin assay results below 0.01 EU/mg, lot/batch numbers, testing date, and signature from an independent ISO 17025 accredited laboratory.
Why is CJC-1295 combined with Ipamorelin in research models?
Preclinical studies show that CJC-1295 (a GHRH analog) and Ipamorelin (a GHS-R1a agonist) trigger dual receptor pathways simultaneously, producing a synergistic pulse of growth hormone that exceeds the effect of either secretagogue alone.
Does Ipamorelin elevate cortisol or prolactin in preclinical models?
In vitro and animal models demonstrate that Ipamorelin is highly selective for the GHS-R1a receptor and does not induce statistically significant elevations in ACTH, cortisol, or prolactin compared to older GHRPs.
What solvent is recommended for reconstituting lyophilized peptide blends?
Bacteriostatic water (0.9% benzyl alcohol) is standard for multi-use research vials, as it inhibits microbial growth. Standard sterile 0.9% saline or dedicated assay buffers may be used for immediate single-use cell culture applications.
How should reconstituted CJC-1295 and Ipamorelin be stored?
Reconstituted liquid aliquots should be stored at 2°C to 8°C and used within 14–28 days. Avoid repeated freeze-thaw cycles, which break peptide bonds and cause aggregation.
What is the difference between CJC-1295 with DAC and CJC-1295 without DAC?
CJC-1295 with DAC contains a Drug Affinity Complex that covalently binds to albumin, extending its biological half-life to several days. CJC-1295 without DAC (Modified GRF 1-29) has a short half-life (~30 minutes), creating a physiological, pulsatile GH release curve.
Are PX1 Research compounds manufactured in the USA?
Yes. All PX1 Research peptides are synthesized in USA-based, GMP-compliant facilities and undergo independent third-party testing at ISO 17025 accredited analytical laboratories.
Can these compounds be used for human administration?
No. All products supplied by PX1 Research are strictly for laboratory research, in vitro assays, and preclinical animal models. They are not for human consumption, medical, clinical, or therapeutic use.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.